ArticleClinical and translational radiation oncology2020

Stereotactic radiotherapy with focal boost for intermediate and high-risk prostate cancer: Initial results of the SPARC trial.

Luke Nicholls et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.